Dr Kennaugh, a principal in the firm’s Perth office, is the first woman to join the board.

Her practice is focused on life sciences and pharmaceutical patents across Australia and New Zealand, for domestic and international clients, according to a statement from Wrays. She has a background in biochemistry and spent 10 years in research before joining Wrays in 1999.

“It’s an honour to become part of the board and I’m looking forward to putting my years of experience in both research and the patent profession towards this new opportunity,” Dr Kennaugh said.

“As the first female appointee, I’m pleased that Wrays, and the industry as a whole, is making strides towards reflecting the diversity and contributions of all people within our profession.”

Adelaide-based principal Mr Humphris is the firm’s first board member based outside Western Australia.

He works primarily in patent prosecution and litigation in the pharmaceutical and biotechnology industries. He is also the director of Wrays Lawyers nationally and the group head for international business development.

“It’s a privilege to be the first person outside of WA to join the board, and reflect the transformation of Wrays into a firm with truly national clients and national perspective,” Mr Humphris said.

VIEW ALL

“I’m looking forward to helping further drive Wrays’ growth both in Australia and overseas.”

Wrays chairman Gary Cox welcomed the two new directors.

“Both Linda and Craig are proven performers who have built their own practices and made a significant contribution to our clients’ success and the firm’s continued growth,” he said.

“Their appointments reflect the growth and evolution of Wrays into a diverse, national firm. It is an important milestone in our progress, and I’m confident Linda and Craig will bring new perspectives and ideas to the board to help us better serve our clients and further expand our horizons.”

Pictured top to bottom: Linda Kennaugh and Craig Humphris